1st Jun 2016 11:30 am |
RNS |
Total Voting Rights |
27th May 2016 12:36 pm |
RNS |
POSITIVE CHMP OPINION IN EU FOR SAXA/DAPA |
27th May 2016 7:03 am |
RNS |
Positive results from AstraZeneca Faslodex trial |
27th May 2016 7:00 am |
RNS |
AstraZeneca receives CRL from US FDA for ZS-9 |
23rd May 2016 4:00 pm |
RNS |
Director/PDMR Shareholding |
18th May 2016 7:00 am |
RNS |
TOP-LINE RESULTS FROM LYNPARZA GOLD TRIAL |
17th May 2016 7:00 am |
RNS |
POSITIVE BENRALIZUMAB RESULTS IN SEVERE ASTHMA |
12th May 2016 7:00 am |
RNS |
SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN US |
11th May 2016 5:30 pm |
RNS |
Publication of Final Terms |
9th May 2016 5:35 pm |
RNS |
Launch and pricing of EUR2.2bn bond issues |
5th May 2016 3:00 pm |
RNS |
Publication of a Prospectus |
3rd May 2016 1:30 pm |
RNS |
Total Voting Rights |
3rd May 2016 7:01 am |
RNS |
AstraZeneca completes divestment of Imdur |
3rd May 2016 7:00 am |
RNS |
AZ COMPLETES ACQUISITION OF TAKEDA RESPIRATORY |
29th Apr 2016 5:30 pm |
RNS |
Result of AGM |
29th Apr 2016 12:46 pm |
RNS |
POSITIVE CHMP OPINION FOR CAZ AVI |
29th Apr 2016 7:00 am |
RNS |
AZN: 1st Quarter Results |
28th Apr 2016 9:00 am |
RNS |
Notice of Results |
26th Apr 2016 9:29 am |
RNS |
AZ enters US licensing agreement with Ironwood |
26th Apr 2016 7:01 am |
RNS |
BEVESPI AEROSPHERE APPROVED BY US FDA FOR COPD |
8th Apr 2016 7:00 am |
RNS |
AZ TO CONTINUE PIVOTAL ALZHEIMER'S CLINICAL TRIAL |
1st Apr 2016 11:30 am |
RNS |
Total Voting Rights |
29th Mar 2016 7:00 am |
RNS |
TAGRISSO APPROVED IN JAPAN FOR CANCER PATIENTS |
24th Mar 2016 3:00 pm |
RNS |
Director/PDMR Shareholding |
23rd Mar 2016 7:00 am |
RNS |
AZ reports results from Brilinta stroke trial |
18th Mar 2016 10:30 am |
RNS |
Notice of AGM |
8th Mar 2016 6:29 pm |
RNS |
Filing of Form 20-F with SEC |
8th Mar 2016 12:00 pm |
RNS |
Annual Financial Report |
1st Mar 2016 2:30 pm |
RNS |
Total Voting Rights |
29th Feb 2016 1:45 pm |
RNS |
AZ REPORTS TOP-LINE RESULT OF TREMELIMUMAB TRIAL |
29th Feb 2016 7:59 am |
RNS |
AZ enters licensing agreement with CMS for Plendil |
26th Feb 2016 12:00 pm |
RNS |
Director/PDMR Shareholding |
25th Feb 2016 8:57 am |
RNS |
ACALABRUTINIB ORPHAN DRUG DESIGNATION RECOMMENDED |
19th Feb 2016 7:05 am |
RNS |
BRILIQUE APPROVED IN EU FOR HEART ATTACK PATIENTS |
19th Feb 2016 7:00 am |
RNS |
ZURAMPIC APPROVED IN EU FOR GOUT PATIENTS |
17th Feb 2016 7:00 am |
RNS |
Durvalumab granted BTD by FDA for cancer patients |
16th Feb 2016 8:01 am |
RNS |
NEW EXTERNAL BOARD APPOINTMENT |
4th Feb 2016 7:00 am |
RNS |
AstraZeneca Full-Year and Q4 2015 Results |
3rd Feb 2016 9:00 am |
RNS |
Notice of Results |
3rd Feb 2016 7:00 am |
RNS |
TAGRISSO approved in EU for cancer patients |